BNGO
- Bionano Genomics, Inc.
()
Overview
Company Summary
Bionano Genomics, Inc. (BNGO) is a company that specializes in genome analysis technologies. Their primary focus is on the development and commercialization of the Saphyr system, which is a platform used for structural variation detection in the field of genomics.
Genomics is the study of an organism's complete set of genetic material, including genes and their functions. Structural variations refer to changes in the structure of chromosomes or DNA molecules, such as deletions, duplications, inversions, or translocations. These variations are known to play a significant role in genetic diseases and have implications in various fields, including cancer research.
The Saphyr system developed by Bionano Genomics offers a high-resolution genomic map, providing researchers with a comprehensive view of an individual's genetic makeup. By analyzing structural variations accurately and on a large scale, researchers can gain valuable insights into the identification and understanding of diseases caused by genomic variants.
The Saphyr system utilizes a technology called optical genome mapping (OGM), which uses high-speed imaging to capture digital images of single DNA molecules. These images are then analyzed and reconstructed to create genome maps. This process allows for the detection of structural variations at a level of detail not easily achievable with traditional sequencing methods.
Bionano Genomics aims to provide researchers, clinicians, and biopharmaceutical companies with cutting-edge tools to study and understand the complexities of the genome. By enabling accurate and efficient detection of structural variations, BNGO contributes to advancements in precision medicine, the development of targeted therapies, and the improvement of patient outcomes in various genetic disorders and diseases.